Sabra Reports Q1 Revenue of $221.8M, Exceeds Consensus
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 29 2026
0mins
Should l Buy SBRA?
Reports Q1 revenue $221.8M, consensus $216.4M. Commenting on the first quarter's results, Rick Matros, CEO and Chair, said, "Sabra is pleased to report another quarter with outstanding results. Our year-over-year same-store managed senior housing NOI growth exceeded the two previous quarters as we saw NOI margin growth in our consolidated, unconsolidated and same-store portfolios. Our pipeline remains robust as we closed or have been awarded over $400 million in investments to date, closing in on our investment total for all of 2025. We are also executing on off-market skilled nursing deals with existing operators. Our rent coverage for all triple net asset classes hit new highs, and we are reiterating our full-year guidance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SBRA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SBRA
Wall Street analysts forecast SBRA stock price to rise
7 Analyst Rating
3 Buy
4 Hold
0 Sell
Moderate Buy
Current: 20.580
Low
20.00
Averages
20.83
High
22.00
Current: 20.580
Low
20.00
Averages
20.83
High
22.00
About SBRA
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Its primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. Its investment portfolio primarily comprises skilled nursing/transitional care facilities, senior housing communities (Senior Housing - Leased), behavioral health facilities, and specialty hospitals and other facilities, in each case leased to third-party operators; senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed); investments in joint ventures; loans receivable, and preferred equity investments. Its real estate properties held for investment included 37,047 beds/units, spread across the United States and Canada.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sabra Health Care REIT Q1 2026 Earnings Call Insights
- Strong Investment Liquidity: Sabra has closed or been awarded $400 million in investments year-to-date in Q1 2026, indicating robust deal flow and a strong competitive position in the market, with expectations to materially exceed total investments from 2025.
- Increased Private Pay Concentration: For the first time, private pay concentration has surpassed 50% of the portfolio, enhancing revenue stability and strengthening the company's market position in the healthcare sector.
- Solid Financial Performance: The normalized FFO per share for Q1 was $0.38, and normalized AFFO per share was $0.39, reflecting ongoing improvements in profitability, although management did not provide new per-share guidance figures.
- Strong Dividend Coverage: The Board declared a quarterly cash dividend of $0.30 per share, with a coverage ratio of 77%, indicating robust cash flow management that helps bolster investor confidence.
See More
Sabra (SBRA) Q1 2026 Earnings Transcript
See More
Sabra Health Care Declares Quarterly Dividend of $0.30
- Quarterly Dividend Announcement: Sabra Health Care declares a quarterly dividend of $0.30 per share, consistent with previous distributions, indicating the company's stable cash flow and commitment to shareholder returns.
- Yield Analysis: The forward yield of 5.9% reflects the company's attractiveness in the current market environment, potentially drawing more investor interest towards its stock.
- Financial Performance: Sabra Health Care reported FFO of $0.36, missing expectations by $0.01, while revenue of $211.9 million exceeded forecasts by $9.93 million, demonstrating the company's resilience in revenue growth.
- Future Outlook: Sabra anticipates FFO growth between 4.9% and 5.4% for 2026, while increasing investments in SHOP to capitalize on the upcoming silver tsunami market opportunities.
See More
Sabra Health Care Q1 Earnings Announcement Scheduled
- Earnings Release Date: Sabra Health Care (SBRA) is set to announce its Q1 2023 earnings on April 29th after market close, with consensus estimates predicting a Funds From Operations (FFO) of $0.37 and revenue of $216.44 million.
- FFO Growth Outlook: The company anticipates an FFO growth rate between 4.9% and 5.4% for 2026, indicating a strategic focus on accelerating investments in its Senior Housing Operating Platform (SHOP) to capitalize on demographic trends.
- 2025 Q4 Earnings Review: In its Q4 2025 earnings report, Sabra reported an FFO of $0.36, missing estimates by $0.01, while revenue of $211.9 million exceeded expectations by $9.93 million, demonstrating resilience in revenue growth despite slight FFO shortfall.
- Market Reaction: Although the FFO fell slightly short of expectations, the revenue beat may positively influence the stock price in the short term, reflecting market confidence in the company's future growth potential.
See More
Analysis of Real Estate Investment Trust Yields
- Attractive REIT Yields: With the Fed cutting rates, real estate investment trusts (REITs) are offering yields between 6% and 15%, making them appealing to income-seeking investors, especially as other investment vehicles see declining returns, enhancing REITs' relative attractiveness.
- Sabra Health Care REIT Performance: Sabra Health Care REIT boasts a 6.1% dividend yield and a portfolio of 360 properties; despite the COVID crisis, long-term trends remain favorable, with plans to expand its senior housing operating portfolio through acquisitions.
- Unique Structure of Millrose Properties: Millrose Properties offers a 10.4% dividend yield, operating through option contracts with Lennar to develop residential land, and is expected to maintain or modestly grow its adjusted funds from operations (AFFO) per share, providing stable returns to investors.
- High-Yield MFA Financial: MFA Financial features a remarkable 14.6% dividend yield; despite facing interest rate uncertainties, the company reported better-than-expected distributable earnings per share (DE) in Q4, indicating resilience in a challenging market environment.
See More
SABRA HEALTH CARE REIT, INC.: WELLS FARGO INCREASES TARGET PRICE FROM $21 TO $22
Company Announcement: Sabra Health Care REIT, Inc. has announced an increase in its target price.
New Target Price: The target price has been raised to $22 from the previous $21.
See More
Sabra Health Care REIT Q1 2026 Earnings Call Insights
- Strong Investment Liquidity: Sabra has closed or been awarded $400 million in investments year-to-date in Q1 2026, indicating robust deal flow and a strong competitive position in the market, with expectations to materially exceed total investments from 2025.
- Increased Private Pay Concentration: For the first time, private pay concentration has surpassed 50% of the portfolio, enhancing revenue stability and strengthening the company's market position in the healthcare sector.
- Solid Financial Performance: The normalized FFO per share for Q1 was $0.38, and normalized AFFO per share was $0.39, reflecting ongoing improvements in profitability, although management did not provide new per-share guidance figures.
- Strong Dividend Coverage: The Board declared a quarterly cash dividend of $0.30 per share, with a coverage ratio of 77%, indicating robust cash flow management that helps bolster investor confidence.
See More
Sabra (SBRA) Q1 2026 Earnings Transcript
See More
Sabra Health Care Declares Quarterly Dividend of $0.30
- Quarterly Dividend Announcement: Sabra Health Care declares a quarterly dividend of $0.30 per share, consistent with previous distributions, indicating the company's stable cash flow and commitment to shareholder returns.
- Yield Analysis: The forward yield of 5.9% reflects the company's attractiveness in the current market environment, potentially drawing more investor interest towards its stock.
- Financial Performance: Sabra Health Care reported FFO of $0.36, missing expectations by $0.01, while revenue of $211.9 million exceeded forecasts by $9.93 million, demonstrating the company's resilience in revenue growth.
- Future Outlook: Sabra anticipates FFO growth between 4.9% and 5.4% for 2026, while increasing investments in SHOP to capitalize on the upcoming silver tsunami market opportunities.
See More
Sabra Health Care Q1 Earnings Announcement Scheduled
- Earnings Release Date: Sabra Health Care (SBRA) is set to announce its Q1 2023 earnings on April 29th after market close, with consensus estimates predicting a Funds From Operations (FFO) of $0.37 and revenue of $216.44 million.
- FFO Growth Outlook: The company anticipates an FFO growth rate between 4.9% and 5.4% for 2026, indicating a strategic focus on accelerating investments in its Senior Housing Operating Platform (SHOP) to capitalize on demographic trends.
- 2025 Q4 Earnings Review: In its Q4 2025 earnings report, Sabra reported an FFO of $0.36, missing estimates by $0.01, while revenue of $211.9 million exceeded expectations by $9.93 million, demonstrating resilience in revenue growth despite slight FFO shortfall.
- Market Reaction: Although the FFO fell slightly short of expectations, the revenue beat may positively influence the stock price in the short term, reflecting market confidence in the company's future growth potential.
See More
Analysis of Real Estate Investment Trust Yields
- Attractive REIT Yields: With the Fed cutting rates, real estate investment trusts (REITs) are offering yields between 6% and 15%, making them appealing to income-seeking investors, especially as other investment vehicles see declining returns, enhancing REITs' relative attractiveness.
- Sabra Health Care REIT Performance: Sabra Health Care REIT boasts a 6.1% dividend yield and a portfolio of 360 properties; despite the COVID crisis, long-term trends remain favorable, with plans to expand its senior housing operating portfolio through acquisitions.
- Unique Structure of Millrose Properties: Millrose Properties offers a 10.4% dividend yield, operating through option contracts with Lennar to develop residential land, and is expected to maintain or modestly grow its adjusted funds from operations (AFFO) per share, providing stable returns to investors.
- High-Yield MFA Financial: MFA Financial features a remarkable 14.6% dividend yield; despite facing interest rate uncertainties, the company reported better-than-expected distributable earnings per share (DE) in Q4, indicating resilience in a challenging market environment.
See More
SABRA HEALTH CARE REIT, INC.: WELLS FARGO INCREASES TARGET PRICE FROM $21 TO $22
Company Announcement: Sabra Health Care REIT, Inc. has announced an increase in its target price.
New Target Price: The target price has been raised to $22 from the previous $21.
See More
